Last updated on January 2020

Study to Evaluate the Efficacy Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients

Brief description of study

This will be a double-blind, randomised, placebo-controlled parallel-arm phase II proof of concept in subjects with PD treated with a stable dose of levodopa who are experiencing both end-of-dose wearing off and Levodopa-Induced Dyskinesia (LID)

Clinical Study Identifier: NCT03162874

Find a site near you

Start Over

CHU Gabriel-Montpied

Clermont-Ferrand, France
  Connect »

North Tyneside General Hospital

North Shields, United Kingdom
  Connect »